Pure Global

Anti-Cyclic Citrullinated Peptide Test - India CDSCO Medical Device Registration

Anti-Cyclic Citrullinated Peptide Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000103_e4f1aa9244eca45cc0e24a8004442663_ed699eed09e4f369552b1ba02d8e3791. This device is marketed under the brand name RF-IgM. The license holder is Genovik Biotech Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Rajasthan.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
Anti-Cyclic Citrullinated Peptide Test
UID: MFG/IVD/2023/000103_e4f1aa9244eca45cc0e24a8004442663_ed699eed09e4f369552b1ba02d8e3791

Brand Name

RF-IgM

Device Class

Class B

Approving Authority

Rajasthan

Product Information

The Anti-Cyclic Citrullinated Peptide (RF-IgM) Test is applicable to the quantitative detection of the concentration of anti-cyclic citrullinate peptide antibody in human specimens (RF-IgM) in vitro. which has high specificity and sensitivity for rheumatoid arthritis and can assist clinical diagnosis and treatment prognosis of rheumatoid arthritis

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing